Tiratricol News
Tiratricol currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Tiratricol with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Emcitate is indicated for the treatment of peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency (Allan-Herndon-Dudley Syndrome), from birth.
- Evidence level: L5
- Predicted indications (20):
- migraine with brainstem aura (93.3%)
- migraine disorder (92.3%)
- seborrheic dermatitis (80.6%)
- amenorrhea (disease) (80.1%)
- polyp of vocal cord (59.1%)
- polyp of middle ear (58.8%)
- uterine polyp (58.8%)
- ocular tuberculosis (58.6%)
- polyp of frontal sinus (58.1%)
- polyp of ureter (58.1%)
- polyp of external auditory canal (57.6%)
- polyp of vulva (57.3%)
- epulis (57.2%)
- sunburn (57.0%)
- fibroepithelial polyp (56.8%)
- acne (disease) (56.6%)
- obsolete pathologic fracture (56.4%)
- arteriosclerosis obliterans (56.2%)
- obsolete functional visual loss (56.2%)
- guttate psoriasis (56.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.